Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
2,570 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00060944 | A Study to Assess Treatment With 2 Different Dosing Schedules of Trabectidin Administered to Patients With Advanced Cancer | completed | Phase 2 | 271 | Johnson & Johnson Pharmaceutical Research & Development, L.L.C.INDUSTRY | 8 | Sep 8, 2014 | clinicaltrials |
| NCT00576758 | GAUSS: A Study of Obinutuzumab (RO5072759) in Patients With Indolent Non-Hodgkin's Lymphoma | completed | Phase 2 | 175 | Hoffmann-La RocheINDUSTRY | 17 | Aug 19, 2014 |
| clinicaltrials |
| NCT00338130 | Randomised Study to Compare the Efficacy of AZD6244 vs TMZ | completed | Phase 2 | 239 | AstraZenecaINDUSTRY | 10 | Aug 13, 2014 | clinicaltrials |
| NCT00021242 | Docetaxel in Treating Children With Relapsed or Refractory Acute Lymphoblastic or Acute Myeloid Leukemia | completed | Phase 2 | 12 | Children's Oncology GroupNETWORK | 7 | Aug 8, 2014 | clinicaltrials |
| NCT00517699 | A Study of MabThera (Rituximab) in Primary Central Nervous System Lymphoma. | terminated | Phase 2 | 5 | Hoffmann-La RocheINDUSTRY | 1 | Aug 8, 2014 | clinicaltrials |
| NCT01104675 | Study of Oral ENMD-2076 Administered to Patients With Ovarian Cancer | completed | Phase 2 | 64 | CASI pharmaceuticals, Inc.INDUSTRY | 2 | Aug 6, 2014 | clinicaltrials |
| NCT00002941 | Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Recurrent or Refractory Hodgkin's or Non-Hodgkin's Lymphoma | completed | Phase 2 | 69 | Children's Oncology GroupNETWORK | 7 | Aug 1, 2014 | clinicaltrials |
| NCT00948090 | PK-directed Dose Adjustment of IV Busulfan Conditioning Regimen for Autologous Stem Cell Transplant in Lymphoma Patients | completed | Phase 2 | 207 | Otsuka Pharmaceutical Development & Commercialization, Inc.INDUSTRY | 2 | Jul 31, 2014 | clinicaltrials |
| NCT00003234 | Vinorelbine in Treating Children With Recurrent or Refractory Cancers | completed | Phase 2 | 50 | Children's Oncology GroupNETWORK | 7 | Jul 28, 2014 | clinicaltrials |
| NCT00003783 | Combination Chemotherapy in Treating Children With Very High Risk Acute Lymphocytic Leukemia | completed | Phase 2 | 36 | Children's Oncology GroupNETWORK | 5 | Jul 28, 2014 | clinicaltrials |
| NCT00003019 | Vinblastine and Methotrexate in Treating Children With Desmoid Tumors | completed | Phase 2 | 28 | Children's Oncology GroupNETWORK | 3 | Jul 25, 2014 | clinicaltrials |
| NCT00003178 | Chemotherapy in Treating Children With Recurrent Acute Myeloid Leukemia | completed | Phase 2 | 120 | Children's Oncology GroupNETWORK | 7 | Jul 25, 2014 | clinicaltrials |
| NCT00003573 | Etoposide Plus Radiation Therapy Followed by Combination Chemotherapy in Treating Children With Newly Diagnosed Advanced Medulloblastoma | completed | Phase 2 | 53 | Children's Oncology GroupNETWORK | 5 | Jul 25, 2014 | clinicaltrials |
| NCT00003671 | Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphocytic Leukemia | completed | Phase 2 | 59 | Children's Oncology GroupNETWORK | 5 | Jul 25, 2014 | clinicaltrials |
| NCT01151215 | Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer(MINT) | terminated | Phase 2 | 482 | AstraZenecaINDUSTRY | 18 | Jul 25, 2014 | clinicaltrials |
| NCT01424930 | A Study to Determine the Short-Term Safety of Continuous Dosing of Abiraterone Acetate and Prednisone in Modified Fasting and Fed States to Patients With Metastatic Castration-Resistant Prostate Cancer | completed | Phase 2 | 25 | Janssen-Ortho Inc., CanadaINDUSTRY | 1 | Jul 25, 2014 | clinicaltrials |
| NCT00002590 | Combination Chemotherapy in Treating Children With Lymphoma | completed | Phase 2 | 221 | Children's Oncology GroupNETWORK | 3 | Jul 24, 2014 | clinicaltrials |
| NCT00002594 | Combination Chemotherapy Followed by Bone Marrow and/or Peripheral Stem Cell Transplantation in Treating Patients With Recurrent Medulloblastoma or CNS Germ Cell Tumors | completed | Phase 2 | 31 | Children's Oncology GroupNETWORK | 6 | Jul 24, 2014 | clinicaltrials |
| NCT00002621 | Interferon Alfa in Treating Children With HIV-Related Cancer | completed | Phase 2 | 8 | Children's Oncology GroupNETWORK | 4 | Jul 24, 2014 | clinicaltrials |
| NCT00002785 | Combination Chemotherapy, Bone Marrow Transplantation, and Radiation Therapy in Treating Infants With Acute Lymphoblastic Leukemia | completed | Phase 2 | — | Children's Oncology GroupNETWORK | 3 | Jul 24, 2014 | clinicaltrials |
| NCT00002805 | Combination Chemotherapy in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome | completed | Phase 2 | 115 | Children's Oncology GroupNETWORK | 3 | Jul 24, 2014 | clinicaltrials |
| NCT00003735 | Chemotherapy in Treating Children With Relapsed Acute Leukemia, Acute Myeloid Leukemia, or Blastic Phase Chronic Myelogenous Leukemia | completed | Phase 2 | 11 | Children's Oncology GroupNETWORK | 3 | Jul 24, 2014 | clinicaltrials |
| NCT00373204 | Study of the Effect on Non-small Cell Lung Cancer of the Investigational Drug Motexafin Gadolinium When Used in Combination With Docetaxel (Taxotere) | terminated | Phase 2 | 50 | Pharmacyclics LLC.INDUSTRY | 4 | Jul 24, 2014 | clinicaltrials |
| NCT01081301 | Living With Hope Program for Rural Women Caregivers(LWH) | completed | Phase 2 | 36 | University of SaskatchewanOTHER | 1 | Jul 23, 2014 | clinicaltrials |
| NCT01447927 | Metformin Hydrochloride in Preventing Esophageal Cancer in Patients With Barrett Esophagus | completed | Phase 2 | 93 | National Cancer Institute (NCI)NIH | 3 | Jul 21, 2014 | clinicaltrials |
| NCT00246090 | A Phase II Study of E7389 in Patients With Breast Cancer, Previously Treated With Anthracycline, Taxane and Capecitabine | completed | Phase 2 | 298 | Eisai Inc.INDUSTRY | 2 | Jul 14, 2014 | clinicaltrials |
| NCT00467844 | Study of GTx-024 on Muscle Wasting (Cachexia) Cancer. | completed | Phase 2 | 159 | GTxINDUSTRY | 2 | Jul 11, 2014 | clinicaltrials |
| NCT00044343 | GW572016, An Oral Drug For Colorectal Cancer Patients Having Prior Therapy With 5-FU Plus CPT-11 And/Or Oxaliplatin | completed | Phase 2 | 80 | GlaxoSmithKlineINDUSTRY | 2 | Jul 10, 2014 | clinicaltrials |
| NCT00862784 | A Study of IMC-1121B (Ramucirumab) in Colorectal Cancer | completed | Phase 2 | 48 | Eli Lilly and CompanyINDUSTRY | 2 | Jun 17, 2014 | clinicaltrials |
| NCT00593853 | Efficacy Study of Methylphenidate Hydrochloride to Reduce Fatigue in Prostate Cancer Patients Receiving Hormone Therapy | terminated | Phase 2 | 33 | University Health Network, TorontoOTHER | 1 | Jun 4, 2014 | clinicaltrials |
| NCT00188175 | IMRT Lower Limb Soft Tissue Sarcoma | completed | Phase 2 | 59 | University Health Network, TorontoOTHER | 1 | Jun 3, 2014 | clinicaltrials |
| NCT00368927 | Sulindac in Preventing Lung Cancer in Current or Former Smokers With Bronchial Dysplasia | completed | Phase 2 | 61 | National Cancer Institute (NCI)NIH | 2 | May 23, 2014 | clinicaltrials |
| NCT00392444 | Sunitinib in Treating Patients With Advanced Malignant Pleural Mesothelioma | completed | Phase 2 | 39 | National Cancer Institute (NCI)NIH | 1 | May 21, 2014 | clinicaltrials |
| NCT00493428 | Treatment of Non-Metastatic Hepatocellular Carcinoma in Humans by Increasing Gabaergic Activity: A Pilot Study | withdrawn | Phase 2 | 0 | University of ManitobaOTHER | 1 | May 16, 2014 | clinicaltrials |
| NCT00392496 | Sunitinib in Treating Patients With Relapsed or Refractory Diffuse or Mediastinal Large B-Cell Lymphoma | completed | Phase 2 | 19 | National Cancer Institute (NCI)NIH | 1 | May 15, 2014 | clinicaltrials |
| NCT00069758 | Safety and Activity of SDX-105 (Bendamustine) in Patients With Rituximab Refractory Non-Hodgkin's Lymphoma | completed | Phase 2 | 72 | CephalonINDUSTRY | 2 | May 9, 2014 | clinicaltrials |
| NCT00076349 | SDX-105 in Combination With Rituxan for Patients With Relapsed Indolent or Mantle Cell Non-Hodgkin's Lymphoma (NHL) | completed | Phase 2 | 66 | CephalonINDUSTRY | 3 | May 9, 2014 | clinicaltrials |
| NCT00121420 | Study of Motexafin Gadolinium With Whole Brain Radiation Therapy Followed by Stereotactic Radiosurgery Boost in the Treatment of Patients With Brain Metastases | terminated | Phase 2 | 45 | Pharmacyclics LLC.INDUSTRY | 2 | May 9, 2014 | clinicaltrials |
| NCT00236093 | Extension Study of ACTIQ Treatment for Children and Adolescents With Breakthrough Pain | completed | Phase 2 | — | CephalonINDUSTRY | 3 | May 9, 2014 | clinicaltrials |
| NCT01266967 | A Study of GSK2118436 in BRAF Mutant Metastatic Melanoma to the Brain(Break MB) | completed | Phase 2 | 172 | GlaxoSmithKlineINDUSTRY | 6 | May 8, 2014 | clinicaltrials |
| NCT01129622 | Effect of Aromatase Inhibitors on Breast Magnetic Resonance Imaging (MRI)(RFCLET2) | completed | Phase 2 | 16 | Mount Sinai Hospital, CanadaOTHER | 1 | May 1, 2014 | clinicaltrials |
| NCT01124786 | A Study Comparing CO-1.01 With Gemcitabine as First Line Therapy in Patients With Metastatic Pancreatic Adenocarcinoma (LEAP) | completed | Phase 2 | 367 | Clovis Oncology, Inc.INDUSTRY | 15 | Apr 17, 2014 | clinicaltrials |
| NCT00410514 | A Study of Mirabegron (YM178) in Men With Lower Urinary Tract Symptoms (LUTS) and Bladder Outlet Obstruction (BOO) | completed | Phase 2 | 200 | Astellas Pharma IncINDUSTRY | 2 | Apr 4, 2014 | clinicaltrials |
| NCT00452556 | The ELDORADO (Eligard®, Docetaxel and Radiotherapy) Study | unknown | Phase 2 | 86 | Nova Scotia Cancer CentreOTHER | 1 | Mar 19, 2014 | clinicaltrials |
| NCT01116635 | Clinical Study Examining the Safety and Efficacy of Doxorubicin Drug Eluting Microspheres Transarterial Embolization in the Setting of Hepatocellular Carcinoma (HCC) | completed | Phase 1 / Phase 2 | 24 | University of British ColumbiaOTHER | 1 | Mar 17, 2014 | clinicaltrials |
| NCT00396266 | AMD3100 (Plerixafor) Given to NHL and MM Patients to Increase the Number of PBSCs When Given a Mobilizing Regimen of G-CSF | completed | Phase 2 | 22 | Genzyme, a Sanofi CompanyINDUSTRY | 1 | Mar 7, 2014 | clinicaltrials |
| NCT00849472 | Treatment With Pazopanib for Neoadjuvant Breast Cancer | completed | Phase 2 | 101 | GlaxoSmithKlineINDUSTRY | 2 | Mar 4, 2014 | clinicaltrials |
| NCT00004010 | Combination Chemotherapy and Radiation Therapy in Treating Children With Previously Untreated Stage II, Stage III, or Stage IV Hodgkin's Disease | completed | Phase 2 | 99 | Children's Oncology GroupNETWORK | 3 | Feb 26, 2014 | clinicaltrials |
| NCT00028795 | Chemotherapy and Radiation Therapy After Surgery in Treating Children With Newly Diagnosed Astrocytoma, Glioblastoma Multiforme, Gliosarcoma, or Diffuse Intrinsic Pontine Glioma | completed | Phase 2 | 170 | Children's Oncology GroupNETWORK | 7 | Feb 21, 2014 | clinicaltrials |
| NCT00006462 | Gemcitabine in Treating Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia | completed | Phase 2 | 32 | Children's Oncology GroupNETWORK | 7 | Feb 20, 2014 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials